AKG-2xx

N/A

Report date: 2025/05/06 16:25:16

Base Information

Drug NameAKG-2xx
Drug Alias NameAKG-2xx
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkagera Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesBill & Melinda Gates Foundation TrustAkagera Medicines IncNational Institutes Of Health +[4] 
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A